Does ciprofloxacin cure non gonococcal urethritis?

Non-gonococcal urethritis (NGU) is a common sexually transmitted infection (STI) caused by a variety of bacteria, including Chlamydia trachomatis and Mycoplasma genitalium. Ciprofloxacin, a fluoroquinolone antibiotic, is effective in treating several types of bacterial infections, but its efficacy in treating NGU caused by specific pathogens may vary.

For Chlamydia trachomatis infection, ciprofloxacin is generally recommended as an alternative treatment option, especially in cases where doxycycline is not tolerated or not recommended due to drug resistance. Azithromycin is usually the preferred first-line treatment for Chlamydia, but ciprofloxacin can be an effective alternative with high cure rates.

Regarding Mycoplasma genitalium infection, ciprofloxacin is generally not considered the first-line treatment. However, studies have suggested that ciprofloxacin may be effective in treating M. genitalium in certain cases. Some evidence indicates that dual therapy with azithromycin and ciprofloxacin may improve treatment outcomes for M. genitalium infection compared to either antibiotic alone.

It's important to note that the specific treatment recommendations for NGU can vary based on the causative organism, local resistance patterns, and individual patient factors. Therefore, it's essential for individuals experiencing symptoms of NGU to seek appropriate medical evaluation from a healthcare provider for proper diagnosis and appropriate treatment. Self-medication without proper medical advice can lead to inadequate treatment and potential complications.